Medical device maker Baxter International Inc. (NYSE: BAX) announced financial results for the third quarter of 2024, reporting a modest increase in sales from continuing operations.
Sales from continuing operations were $2.70 billion in the September quarter, up 4% on both reported and constant currency basisThird-quarter worldwide sales were $3.85 billion, which includes continuing operations sales of $2.70 billion and discontinued operations sales of $1.15 billionTotal Baxter earnings per share were $0.27 in Q3, on a reported basis; adjusted earnings came in at $0.80 per shareQ3 net income attributable to the company was $140 million, compared to $2.51 billion in the prior year quarterOn an adjusted basis, earnings third-quarter earnings edged down to $0.80 per share from $0.82 per share last year
The post Earnings Summary: Baxter International reports higher sales for Q3 2024 first appeared on AlphaStreet.
—
Blog powered by G6
Disclaimer! A guest author has made this post. G6 has not checked the post. its content and attachments and under no circumstances will G6 be held responsible or liable in any way for any claims, damages, losses, expenses, costs or liabilities whatsoever (including, without limitation, any direct or indirect damages for loss of profits, business interruption or loss of information) resulting or arising directly or indirectly from your use of or inability to use this website or any websites linked to it, or from your reliance on the information and material on this website, even if the G6 has been advised of the possibility of such damages in advance.
For any inquiries, please contact [email protected]
